NIA SBIR Phase II
Funds small businesses advancing aging biology and Alzheimer's disease technologies through full development execution.
The National Institute on Aging (NIA) SBIR Phase II program funds full R&D execution by U.S. small businesses that have completed a qualifying Phase I project on the same technology or innovation. NIA manages approximately $150 million per year in combined SBIR and STTR grants, making it the largest federal funder of early-stage aging-related R&D. Phase II awards are substantially larger than Phas…
Phase II full R&D execution by small businesses expanding successful Phase I work in aging biology, Alzheimer's disease, and AD/ADRD interventions.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline
Guides for this application
All guides →SBIR/STTR Grants for Deeptech Startups
A practical guide to SBIR and STTR grants for deeptech startups, including agency fit, Phase I and II logic, eligibility, budgets, and review criteria.
DocumentsNIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
More from NIA
All grants from this funder →2026 NIA Mentorship Prize Competition
🇺🇸NIA · United States
Pays $100,000 to each of up to six faculty mentors recognized for outstanding aging-research mentorship.
NIA SBIR Phase I
🇺🇸NIA · United States
Supports small businesses developing aging and memory technologies at the feasibility stage.
NIA STTR Phase I
🇺🇸NIA · United States
Supports small businesses partnering with universities on aging innovation at feasibility stage.
NIA Alzheimer's Drug-Development Program
🇺🇸NIA · United States
Funds collaborative research alliances that accelerate Alzheimer's drug development in the United States.
NIA R01: Drug Repositioning and Combination Therapy for Alzheimer's Disease
NIA · United States
Funds researchers combining computational and experimental approaches to test repositioned drugs for Alzheimer's disease treatment through NIH R01 grants.
NIA Start-Up Challenge
🇺🇸NIA · United States
Funds US entrepreneurs and small businesses developing healthy-aging technologies through NIA's Start-Up Challenge cash prizes and accelerator.
Similar grants
Browse the directory →
NIH SBIR Phase II
🇺🇸NIH SEED · United States
Supports United States biomedical small businesses advancing successful feasibility work into scale-up development.
NIDCD SBIR Phase II
🇺🇸NIDCD · United States
Funds follow-up development for small businesses extending early sensory communication technologies into practical products.
NSF SBIR Phase II
🇺🇸NSF · United States
Funds United States deep-tech startups extending proven early projects into substantial technology development.
NIH SBIR Phase I
🇺🇸NIH SEED · United States
Funds early stage United States biomedical teams through NIH seed support for feasibility work on prototype ready ideas.
NCATS SBIR Phase II
🇺🇸NCATS · United States
Backs small businesses scaling proven translational findings into applied solutions and early market readiness.
NIDCD SBIR Phase I
🇺🇸NIDCD · United States
Supports United States. small businesses developing hearing, balance, and speech sensory technologies.